Focus box
Jeffrey Shapiro Q&A: FDA device regulation in the pandemic and beyond
The Covid-19 pandemic has created both opportunities and obstacles for the medtech industry. Where those in the diagnostics space saw…
Kar-go: could an autonomous robot be the new face of drug transport?
Over the course of the Covid-19 pandemic, the physical world of retail has become less accessible to consumers, driving many…
What the UK’s finalised post-Brexit legislation means for medtech
After several tumultuous years attempting to extricate itself from the EU, the UK finally completed the withdrawal process at the…
Just a swipe away: how the NHS plans to offer health records on iPhone
In recent years, we have all grown accustomed to having reams of data at our fingertips. Our financial information is…
Omar Ahmad Q&A: medtech’s quest for post-Covid success in 2021
2020 was undoubtedly defined by Covid-19. For the global medtech industry the pandemic had many knock-on effects, both in terms…
NightWare vs nightmares: the sleep tech app helping break PTSD patterns
Dreams are an enduring mystery for scientists and psychologists. While researchers have come to understand the neuroscience behind what happens…
Virtual Covid-19 wards: cutting hospital admissions with remote care
In the UK and across the world, hospitals have seen record admissions this winter amid the ongoing Covid-19 pandemic. Scientists…
Could CRISPR reinvent the Covid-19 test?
Since the start of the Covid-19 outbreak, the gold standard for testing has been polymerase chain reaction (PCR). With the…
Roundtable: what can medtech expect from 2021?
We’ve heard from: Limbic CEO Ross Harper Visionable CEO Alan Lowe S3 Connected Health president Jim O’Donoghue emocha Health CEO…